EVA BARTLETT: Open Payments
NPI 1912044215 · SHERIDAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 41 payments from 17 companies in 2025. Trend: 2023 $321 · 2024 $868 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Novo Nordisk Inc | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Amgen Inc. | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Indivior Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $32 |
Products named: CAPLYTA, VRAYLAR, Wegovy, FANAPT, MAVYRET, Auvelity, JARDIANCE, SUBLOCADE.
Industry payments across MI — which companies pay providers there.
